Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. (RXRX) Number of Employees – History & Annual Headcount
Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.
SEC EDGAR · FMP · RXRX · as of Feb 25, 2026
Latest filing snapshot
Recursion Pharmaceuticals, Inc. (RXRX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗
RXRX Employee Count
2021 – 2025 · Annual · SEC filingSource: SEC annual filings · Hover bar to view year data · Click to view original filing
Employees History
| Filing Date | Employees | Change (1Y) | Growth (1Y) | SEC filing link |
|---|---|---|---|---|
| 2026-02-25 | 600 | -200 | -25.00% | |
| 2025-02-28 | 800 | +300 | +60.00% | |
| 2024-02-29 | 500 | +0 | +0.00% | |
| 2023-02-27 | 500 | +100 | +25.00% | |
| 2022-03-23 | 400 | — | — |
▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.
Related Companies — Employee Count
Biotechnology
About RXRX employees
RXRX Employees · Headcount
Recursion Pharmaceuticals, Inc. (RXRX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Recursion Pharmaceuticals, Inc. had 600 full-time employees globally. Full-time employees only. Global consolidated headcount.
Recursion Pharmaceuticals, Inc. employs 600 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $124,468, reflecting the company's operational efficiency.
Recursion Pharmaceuticals, Inc.'s workforce decreased by 200 (25.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.
Recursion Pharmaceuticals, Inc.'s revenue per employee of $124,468 positions it among the notable performers in the Biotechnology sector for operational efficiency.
Frequently Asked Questions
RXRX Employees · 5 questionsAs of the latest SEC 10-K filing (2025), Recursion Pharmaceuticals, Inc. had 600 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.
▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-25